Filing Flows › Teradyne (TER) › Q2 2026
Teradyne (TER) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Teradyne (TER) reported revenue of $1.3B for the second quarter 2026 (Q2 2026), +104% from a year earlier and +4% from the quarter before. Operating margin was 32.9%, net earnings $375M (28.2% of revenue).
Teradyne, Q2 2026: revenue $1.3B (+104% year over year), operating margin 32.9%, net earnings $375M, operating cash flow $469M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | +4% | +104% |
| Gross profit | $795M | +2% | +113% |
| Operating profit | $438M | -7% | +382% |
| Net earnings | $375M | -6% | +378% |
| Operating cash flow | $469M | +77% | +158% |
| Free cash flow | $378M | +89% | +187% |
What changed
Revenue was $1.3B in Q2 2026, up 104% year over year and up 4% from the previous quarter. Product was the largest line at 90% of revenue. Product added $0.67B year over year (up 128%), 99% of the total change.
Gross margin was 59.8%, up 2.6 points from Q2 2025. Operating profit was $0.44B, a 32.9% margin (up 19.0 points year over year). Of the extra revenue versus Q2 2025, 51% reached operating profit, above the 14% margin then. Operating expenses grew 26% against revenue growth of 104%. The fastest-growing cost line was Research & development (+32%). Net earnings were $0.37B, up 378% year over year. The effective tax rate was 15.1%.
Operating cash flow was $0.47B (up 158% year over year), 125% of net earnings. Non-cash charges added back $0.03B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.04B. Capital expenditures of $0.09B left free cash flow of $0.38B.
Questions
What was Teradyne's revenue in the second quarter 2026?
Teradyne (TER) reported revenue of $1.3B for the second quarter 2026 (Q2 2026), +104% from a year earlier and +4% from the quarter before.
Was Teradyne profitable in the second quarter 2026?
Operating profit was $438M (32.9% of revenue) and net earnings $375M.
Source: Teradyne 10-Q on SEC EDGAR.